Trial in progress: ENCORE—Multicenter prospective registry of sequential antibody drug conjugates (ADCs) in HER2 negative metastatic breast cancer (MBC) (TBCRC-067).

Authors: Laura Ann Huppert, Leif Ellisen, Carey K. Anders, Claudine Isaacs, Cesar Augusto Santa-Maria, Jesus Del Santo Anampa, Angela DeMichele, Marija Balic, Jennifer M. Specht, Maryam B. Lustberg, Antonio C Wolff, Ian E. Krop, Hope S. Rugo

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps1137

Source: Full article

---

Abstract

TPS1137